--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
REVB Revelation Biosciences
- 0.2950
- -0.0196-6.23%
Close Dec 20 16:00 ET
- 0.3005
- +0.0055+1.86%
Post 20:01 ET
1.91MMarket Cap-0.02P/E (TTM)
0.3180High0.2950Low477.71KVolume0.3100Open0.3146Pre Close145.73KTurnover11.14%Turnover RatioLossP/E (Static)6.46MShares25.260052wk High0.71P/B1.26MFloat Cap0.295052wk Low--Dividend TTM4.29MShs Float11854.5000Historical High--Div YieldTTM7.31%Amplitude0.2950Historical Low0.3050Avg Price1Lot Size
Revelation Biosciences Key Stats
Revelation Biosciences Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Revelation Biosciences Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.